Growing concerns about family planning, rising availability and accessibility of ECP and innovative marketing strategies like investments in social media marketing platforms in order to channelize the product are the major drivers for ECP market.
Browse Full Report: Emergency Contraceptive Pills Market
According to Goldstein Research, emergency contraceptive pills market size is set to reach USD 1.25 billion by 2024, at a CAGR of 1.89% over the forecast years owing to increasing usage of these pills among older women and the widespread availability of products in distribution stores.
Geographically, North America accounted for about 40% of ECP market share in 2016 owing to presence of favorable government initiatives and social marketing initiatives like awareness programs to offer creative, effective, and successful ideas about reproductive health products and services.
Unisex Contraceptive Pills
Researchers have found the switch that triggers ‘power kick’ sperms use for fertilization of eggs, also discovering the source of male infertility. These pills can be used by either of the partners as multiple tissues (brain, lungs, smooth muscles) comprises of related progesterone or steroid receptors that may work in a similar manner in order to trigger vital changes in tissues.
Global Emergency Contraceptive Pills Market
Emergency contraceptive pills report contains detailed overview of the global market in terms of segmentation by EC Pill Type and Sales Channel.
Further, for the in-depth analysis, the report encompasses the industry growth drivers, market challenges, risk analysis, market attractiveness, BPS (Base Point Scale) analysis, Porter’s five force model and SWOT analysis.
Global Emergency Contraceptive Pills market report also provides competitive outlook for some of the major players which includes profiling of companies such as Allergan, Lupin, Mankind, Piramal, Teva, Bayer AG, HLL Life Care, Pfizer, Syzygy Healthcare, V Care Pharma, HRA Pharma, Richter Gedeon Nyrt, Cooper Pharma, Zhejiang Xianju Pharmaceutical Co, etc. The company profiles include business strategy, geographical revenue distribution, major information of the companies which encompasses business outlook, products, services and industries catered, financial analysis of the company and recent developments.
Overall, the report represents comprehensive synopsis on the global emergency contraceptive pills market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
Based in the US, Goldstein Research currently has a strong presence in the American and Asian countries. In the next five years, we strive to expand our reach to 50+ nations spanning across Europe, Asia and parts of the Middle East and Africa. We strive to realize a strong brand presence globally through our quality research and forecasting solutions.
Our mission is simple: to develop insightful business solutions, help our clients make powerful future decisions to keep them well ahead of the game which is the market, and leave a mark across businesses and communities through our well-defined ideas and clear cut forecasts. Backed up by reliable research and impactful statistics, our business solutions empower our clients to grow at a fast pace despite unsettling fluctuations in the market. We believe in vigorous examination of the current market scenario and build around creative ideas and approaches that are most suitable to our clients’ needs and business agenda.